157 related articles for article (PubMed ID: 16618820)
21. Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform.
Jacobs EM; Hendriks JC; van Tits BL; Evans PJ; Breuer W; Liu DY; Jansen EH; Jauhiainen K; Sturm B; Porter JB; Scheiber-Mojdehkar B; von Bonsdorff L; Cabantchik ZI; Hider RC; Swinkels DW
Anal Biochem; 2005 Jun; 341(2):241-50. PubMed ID: 15907869
[TBL] [Abstract][Full Text] [Related]
22. Effect of wine ethanol on serum iron and ferritin levels in patients with coronary heart disease.
de Lorgeril M; Salen P; Boucher F; de Leiris J; Paillard F
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):176-80. PubMed ID: 11590993
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
[TBL] [Abstract][Full Text] [Related]
24. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.
Lee DH; Silventoinen K; Hu G; Jacobs DR; Jousilahti P; Sundvall J; Tuomilehto J
Eur Heart J; 2006 Sep; 27(18):2170-6. PubMed ID: 16772340
[TBL] [Abstract][Full Text] [Related]
25. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
Vari IS; Balkau B; Kettaneh A; André P; Tichet J; Fumeron F; Caces E; Marre M; Grandchamp B; Ducimetière P;
Diabetes Care; 2007 Jul; 30(7):1795-801. PubMed ID: 17416791
[TBL] [Abstract][Full Text] [Related]
26. Intake of ruminant trans fatty acids and risk of coronary heart disease.
Jakobsen MU; Overvad K; Dyerberg J; Heitmann BL
Int J Epidemiol; 2008 Feb; 37(1):173-82. PubMed ID: 18077475
[TBL] [Abstract][Full Text] [Related]
27. T64A polymorphism in beta3-adrenergic receptor gene (ADRB3) and coronary heart disease: a case-cohort study and meta-analysis.
Zafarmand MH; van der Schouw YT; Grobbee DE; de Leeuw PW; Bots ML
J Intern Med; 2008 Jan; 263(1):79-89. PubMed ID: 18088254
[TBL] [Abstract][Full Text] [Related]
28. Stronger symptoms of depression predict high coronary heart disease mortality in older men and women.
Ahto M; Isoaho R; Puolijoki H; Vahlberg T; Kivelä SL
Int J Geriatr Psychiatry; 2007 Aug; 22(8):757-63. PubMed ID: 17133654
[TBL] [Abstract][Full Text] [Related]
29. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
Gosriwatana I; Loreal O; Lu S; Brissot P; Porter J; Hider RC
Anal Biochem; 1999 Sep; 273(2):212-20. PubMed ID: 10469492
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
31. Beta-blockers for coronary heart disease in chronic kidney disease.
Chonchol M; Benderly M; Goldbourt U
Nephrol Dial Transplant; 2008 Jul; 23(7):2274-9. PubMed ID: 18187497
[TBL] [Abstract][Full Text] [Related]
32. Factors accounting for high ferritin levels in obesity.
Lecube A; Hernández C; Pelegrí D; Simó R
Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
[TBL] [Abstract][Full Text] [Related]
33. Relationship between transferrin-iron saturation, alcohol consumption, and the incidence of cirrhosis and liver cancer.
Ioannou GN; Weiss NS; Kowdley KV
Clin Gastroenterol Hepatol; 2007 May; 5(5):624-9. PubMed ID: 17478349
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
Lee DH; Zacharski LR; Jacobs DR
Am Heart J; 2006 Jun; 151(6):1247.e1-7. PubMed ID: 16781229
[TBL] [Abstract][Full Text] [Related]
35. Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.
Ambrus CM; Lajos TZ; Stadler I; Stadler A; Alfano J; Tulumello JA; Ambrus JL
J Med; 1999; 30(3-4):157-67. PubMed ID: 17312669
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
[TBL] [Abstract][Full Text] [Related]
37. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
38. Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke.
Koren-Morag N; Goldbourt U; Tanne D
Am Heart J; 2008 Mar; 155(3):515-20. PubMed ID: 18294489
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study.
Asvold BO; Bjøro T; Nilsen TI; Gunnell D; Vatten LJ
Arch Intern Med; 2008 Apr; 168(8):855-60. PubMed ID: 18443261
[TBL] [Abstract][Full Text] [Related]
40. Erectile dysfunction predicts coronary heart disease in type 2 diabetes.
Ma RC; So WY; Yang X; Yu LW; Kong AP; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
J Am Coll Cardiol; 2008 May; 51(21):2045-50. PubMed ID: 18498959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
